Polyclonal Antibodies
Anti-DLST Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P36957
Item Number : CM0017037
Price varies based on specs and customizations
- Application
- WB, IHC-P, IF/ICC, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 49kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | DLST Rabbit pAb |
| Remarks/Alias | DLTS; KGD2; PGL7; DLST |
| Species | Human |
| GeneID (Human) | 1743 |
| GeneID | 1743 |
| Immunogen | synthetic peptide|A synthetic peptide corresponding to a sequence within amino acids 150-250 of human DLST (NP_001924.2). |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, IHC-P, IF/ICC, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | P36957 |
| Protein Weight | 49kDa |
| Shipping | Ice bag |
Biological Background: DLST Function and Localization
- DLST is the dihydrolipoamide succinyltransferase (E2) component of the 2-oxoglutarate dehydrogenase complex (OGDC), also known as E2K.
- The OGDC catalyzes the conversion of 2-oxoglutarate to succinyl-CoA and CO2, a key reaction in the tricarboxylic acid (TCA) cycle. Related references: PMID:29211711 PMID:30929736
- The OGDC is primarily localized to the mitochondrial matrix, where it functions in energy metabolism.
- A fraction of DLST localizes to the nucleus, where it interacts with KAT2A and provides succinyl-CoA for histone succinylation, a chromatin modification. Related references: PMID:29211711
- DLST contains lipoyl domains essential for its catalytic activity and is subject to post-translational modifications including acetylation and phosphorylation.
- Alternative splicing of DLST yields multiple isoforms, potentially influencing complex assembly or localization.
Experimental Guidance and Technical Tips
- The immunogen is a synthetic peptide spanning amino acids 150–250 of human DLST (NP_001924.2); epitope mapping suggests this region may be exposed in native and denatured conformations.
- For western blot (WB), DLST migrates at approximately 49 kDa; denaturing and reducing conditions are recommended. Validate expression in mitochondrial-rich tissues (e.g., liver, kidney) or cell lines positive for OGDC components.
- For immunohistochemistry (IHC-P) and immunofluorescence (IF/ICC), antigen retrieval may be required for formalin-fixed paraffin-embedded sections. Subcellular staining (mitochondrial and nuclear) should be assessed against known localization patterns.
- The antibody shows cross-reactivity with mouse and rat; verify protocol compatibility when switching species.
- For ELISA applications, consider using the immunogen peptide as a positive control to confirm activity.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio provides diagnostic manufacturers, laboratories, and research institutes with one-stop access to IVD raw materials, including validated antibody pairs, optimized monoclonal/polyclonal antibodies, and bulk ancillary reagents. This anti-DLST antibody serves mitochondrial biology and epigenetic research needs, supporting applications from biomarker discovery to diagnostic assay development. Our supply capabilities extend to rare-target raw-material sourcing, ensuring a streamlined path from concept to clinic.
Product Datasheet
Anti-DLST Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P36957
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!